Scholars Central

Conference abstractPublished 14 Sep 2016

Is there a prophylactic medication in REM sleep disturbances, which hint at synucleinopathies?

Authors: Werner Felix-Martin, Coveñas Rafael

Euro Academy PÃ?¶Ã?Â?neck, Germany Institute of Neuroscience of Castilla and LeÃ?³n, Spain

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: On the DGSM congress 2014, rapid eye movement sleep (REM) behavioural disorders were reported, while the SPECT examination showed an asymmetric description of the dopamine transporter systems. These sleep disturbances predict synucleinopathies such as ParkinsonâÂ?Â?s disease. The present study aims at the question, whether there is a prophylactic mediation for this neurodegenerative disease, will be answered by a neural network in the extrapyramidal system. Material & Methods: The neural network can be described as follows: D1 and D2 dopaminergic neurons in the substantia nigra activate dopaminergic neurons in the caudate nucleus. D1 dopaminergic neurons weakly activate dynorphin neurons, which weakly inhibit via kappa receptors substance P neurons. The latter neurons activate weakly via NK1 receptors GABAergic neurons in the globus pallidus internus. In the caudate nucleus D2 dopaminergic neurons weakly activate GABAergic neurons in the globus pallidus externus, which inhibit glutaminergic neurons in the subthalamic nucleus. The latter neurons strongly inhibit via NMDA receptors D2 dopaminergic neurons in the substantia nigra and GABAergic neurons in the globus pallidus internus. In these nucleus, GABAergic neurons weakly inhibit glutaminergic neurons, which activate other glutaminergic neurons in the cortex. These neurons can activate D1 and D2 dopaminergic neuros in the caudate nucleus. In the globus pallidus internus GABAergic neurons weakly inhibit M4 muscarinic cholinergic, 5-HT2A serotonergic and NTS1 neurotensin neurons in the putamen. The latter neurons transmit a strong postsynaptic excitatory impulse to glutaminergic neurons, which inhibit via NMDA receptors D2 dopaminergic neurons in the putamen. The D2 dopaminergic neurons in the putamen are connected to other dopaminergic neurons in the caudate nucleus. Results: Since in ParkinsonâÂ?Â?s disease, apart from dopamine and actylcholine alterations, a GABA deficiency and a glutamate surplus can be found, it might be possible to weaken the neurotransmitter imbalance by a drug, which has at the same time a GABAA agonistic and an NMDA antagonistic effect. Through the GABAA agonistic effect the acetylcholine, serotonin and neurotensin surplus could be reduced. The NMDA antagonistic effect could increase the dopamine levels through a reduced presynaptic inhibition. Conclusion: It is of important to observe patients with REM sleep behavioural disorders and to minimize the risk for synucleinpathies with an appropriate medication.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Cytology & Histology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cytology & Histology
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Werner Felix-Martin”
  • BylineArticles whose byline prints “Coveñas Rafael”